Literature DB >> 33489380

Management of Neuraxial Analgesia in a Parturient with Factor XIII Deficiency: A Case Report and Proposed Management Algorithm.

David B Carroll1, Conrad Myler1, Natthapol Songdej2, Khaled Sedeek1, Dmitri Bezinover1.   

Abstract

Factor XIII (FXIII) deficiency is a rare coagulation defect that can be associated with significant bleeding. A 28-year-old pregnant woman, with a history of hemorrhagic stroke secondary to severe congenital FXIII deficiency, presented in active labor requesting an epidural. Factor XIII levels had been monitored throughout her pregnancy and treated with intermittent factor XIII infusions to maintain factor levels above 30% of normal. After careful multidisciplinary peripartum evaluation and FXIII replacement, neuraxial analgesia was performed without complication. Neuraxial analgesia can be performed without complication in patients with FXIII deficiency if FXIII levels are carefully managed and no other coagulopathy exists.
Copyright © 2020 David B. Carroll et al.

Entities:  

Year:  2020        PMID: 33489380      PMCID: PMC7790575          DOI: 10.1155/2020/8892225

Source DB:  PubMed          Journal:  Case Rep Anesthesiol        ISSN: 2090-6390


  15 in total

1.  A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency.

Authors:  F DUCKERT; E JUNG; D H SHMERLING
Journal:  Thromb Diath Haemorrh       Date:  1960-12-15

Review 2.  Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.

Authors:  Toshihiko Asahina; Takao Kobayashi; Kinya Takeuchi; Naohiro Kanayama
Journal:  Obstet Gynecol Surv       Date:  2007-04       Impact factor: 2.347

3.  Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.

Authors:  Majid Naderi; Akbar Dorgalaleh; Shaban Alizadeh; Shadi Tabibian; Soudabeh Hosseini; Morteza Shamsizadeh; Taregh Bamedi
Journal:  Int J Hematol       Date:  2014-09-18       Impact factor: 2.490

4.  Minimal factor XIII activity level to prevent major spontaneous bleeds.

Authors:  M Menegatti; R Palla; M Boscarino; P Bucciarelli; L Muszbek; E Katona; M Makris; F Peyvandi
Journal:  J Thromb Haemost       Date:  2017-08-17       Impact factor: 5.824

5.  Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.

Authors:  F Peyvandi; R Palla; M Menegatti; S M Siboni; S Halimeh; B Faeser; H Pergantou; H Platokouki; P Giangrande; K Peerlinck; T Celkan; N Ozdemir; C Bidlingmaier; J Ingerslev; M Giansily-Blaizot; J F Schved; R Gilmore; A Gadisseur; M Benedik-Dolničar; L Kitanovski; D Mikovic; K M Musallam; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

6.  Spinal anaesthesia and caesarean section in a patient with hypofibrinogenaemia and factor XIII deficiency.

Authors:  A A Hanke; O Elsner; K Görlinger
Journal:  Anaesthesia       Date:  2010-03-25       Impact factor: 6.955

Review 7.  Factor XIII deficiency.

Authors:  L Hsieh; D Nugent
Journal:  Haemophilia       Date:  2008-11       Impact factor: 4.287

Review 8.  Blood coagulation factor XIII and factor XIII deficiency.

Authors:  Akbar Dorgalaleh; Jamal Rashidpanah
Journal:  Blood Rev       Date:  2016-06-16       Impact factor: 8.250

Review 9.  Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.

Authors:  Jerrold H Levy; Charles Greenberg
Journal:  Transfusion       Date:  2012-08-28       Impact factor: 3.157

10.  Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy.

Authors:  Scott Dunkley; Julie A Curtin; Anthony J Marren; Robert P Heavener; Simon McRae; Jennifer L Curnow
Journal:  Med J Aust       Date:  2019-03-29       Impact factor: 7.738

View more
  1 in total

1.  The perioperative management of cesarean section in a patient with FXIII deficiency and placenta previa: a case report.

Authors:  Kei Ueda; Kentaro Miyoshi; Shinichi Kai
Journal:  JA Clin Rep       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.